 |
Coartem, a drug composed of both artemether and lumefantrine, which was approved by the U.S. Food and Drug Administration in April 2009, is now available in pharmacies for the treatment of acute, uncomplicated malaria infections in adults and children weighing at least five kilograms (approximately 11 pounds). For Coartem and other antimalarial drug treatment recommendations see, Guidelines for Treatment of Malaria in the United States  [PDF - 72 KB]. See also "FDA Approves Coartem Tablets to Treat Malaria.*"
 Please note: Some of these publications are available for download only as *.pdf files. These files require Adobe Acrobat Reader in order to be viewed. Please review the information on downloading and using Acrobat Reader software.
* Links to non-Federal organizations found at this site are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by CDC or the Federal Government, and none should be inferred. CDC is not responsible for the content of the individual organization Web pages found at these links.
Page last modified : May 21, 2009
Content source: Division of Parasitic Diseases
National Center for Zoonotic, Vector-Borne, and Enteric Diseases (ZVED)
|
|
|
